Key Drivers
- Strong free cashflow
- Thin liquidity
- High intangibles
AIAI Summary
USPH's shift into minority/partnered M&A and IIP/RTM/tech initiatives meaningfully changes the valuation framework—investors should explicitly value optionality from these growth levers while treating execution, integration and refinancing/leverage risk as the primary downside triggers to the current premium multiple.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong free cashflow
- •Thin liquidity
- •High intangibles
USPH posts solid margins, strong FCF and constructive ROIC but is hampered by thin liquidity, high intangibles, quarterly earnings volatility and rich valuation.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Lower lows
- •Rapid pullback
The stock has trended down over the last month from mid‑February peaks into lower highs/lows, trading around $73.86 (roughly 7–8% below its last‑month average) after a ~15% drop, with resistance now at $80–$83 and support in the low‑$70s.
~15% decline from mid‑February mid‑$80s to $73.86 on 2026‑03‑20 indicating accelerated selling
Sentiment & News
Key News Insights:
- •Adjusted EBITDA $95M
- •Analyst upgrades
- •4D Advisors sell‑down
USPH reported FY2025 adjusted EBITDA of $95.0M and secured analyst upgrades and a $104.50 average target after Q4 results and investor outreach, although 4D Advisors sold 110k shares (~$9.34M).
Analyst momentum and management outreach likely lend near‑term support to the stock, but the large institutional sale injects caution into the outlook
Similar Companies in Healthcare
Other companies in the same sector with AI ratings